Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. - Wikidata - wikimedia - TriplyDB

Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.

Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.

http://www.wikidata.org/entity/Q36306315

about

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer Decoding the usefulness of non-coding RNAs as breast cancer markers US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).How many etiological subtypes of breast cancer: two, three, four, or more?A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.Linking signaling pathways to transcriptional programs in breast cancer.Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.New genetic variants improve personalized breast cancer diagnosis Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population The molecular diversity of Luminal A breast tumors.The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients.Ki-67 as a prognostic marker according to breast cancer molecular subtype.Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis.The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.A review of the importance of immune responses in luminal B breast cancer.Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinoma.Progressive polarity loss and luminal collapse disrupt tissue organization in carcinoma.Breast carcinoma with tubulopapillary features: a variant of papillary carcinoma with a stronger correlation with predictors of adverse prognosis.Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.Patients with least aggressive breast cancer still face risk of death years later.Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data.Relative and disease-free survival for breast cancer in relation to subtype: a population-based study.Polyphenols as Promising Drugs against Main Breast Cancer Signatures.Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Network Modularity in Breast Cancer Molecular Subtypes.Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review.Mutation screening of 10 cancer susceptibility genes in unselected breast cancer patients.Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomes.

P2860

Q26740393-1B3ECF6B-0FCA-4BFD-824C-9A13DC47D477 Q28069370-37BF1E17-048F-488D-BE62-7BF2DBE491C1 Q30665329-84D04045-330D-4431-ADA6-6CBD96366D60 Q30813968-3EF97CA5-260E-4A3C-A9C8-CFC5C002133A Q34106175-3557961C-3DFA-4C70-B961-BEA98342DEFA Q34212421-F229B674-37B3-4BB6-9DD6-905016903E73 Q34296534-E6F46E1F-E49A-4F6E-861A-EFFD358014B6 Q34439395-9958F931-910F-4CCD-A271-5F00E3623A8E Q35000289-066991E6-F32C-42DC-9D53-A2AD033533F7 Q35079179-D2C2770C-AC9D-4253-90AC-E99B7C156A7F Q35098946-341E76A8-0296-4D81-BAD8-C6F935447186 Q36214193-EDCFA775-BA2D-4A59-BC06-7E5144860996 Q36235990-1CEA503E-9623-44F3-812E-F9499C002186 Q36495529-BF966B27-6748-4900-8A76-D479626EDCE9 Q36630127-6D292C8D-9169-4325-9FDF-755EE1C11838 Q36891801-CA759F79-0A5A-4C22-8754-B33ECCE2A9EC Q37298868-07CC1508-4EBA-45E4-A62C-1A51C78D1D59 Q37315073-8D0A1E37-E909-44FF-97EA-FD4095B96CB5 Q37364604-5978E38D-364C-41D6-A8E9-439E248114E5 Q37596690-D89B8027-AF72-49A8-99BF-B7522ADC6A7C Q37728699-A97B09D1-A511-4665-98B5-8C734A1F35E9 Q37733409-B6B13906-2BEB-4BB2-9E4D-8EE26E84BEC1 Q38925675-9CE3333A-DEC7-43CA-961D-6F89CFEEBF44 Q39042186-24864A08-1194-4AB3-8C6F-D999D28D2082 Q39239484-39CD41BC-FF89-4EAF-A1E5-21913C3A7ECA Q39311162-32543045-67BB-4F14-8AB7-A734208D130A Q40975730-57A9A7CD-4F76-491A-A5D6-EB0083F4C633 Q42457595-264D2C5A-7521-4012-BD69-E860F0A14AF6 Q42514748-08201A7E-39C8-40A3-BADF-8CEAB2C316DF Q44645452-A8E90205-C99B-48BD-B944-61489D18A9AC Q45067339-1D89782E-A0C1-41AC-8FDB-4ADD3F677D27 Q45214922-7D2B6CE8-4F04-4887-9442-1B78469008D1 Q45944093-AF35C08D-14CD-40E5-AEAB-DDC6104E3EB2 Q46558451-E853B87C-9913-4A37-AEC3-E20D2440E181 Q47136288-309D49DA-2366-4648-8F53-62670BA48867 Q47160829-32A405A6-3ACF-4901-93A6-9BDCDF43F183 Q47165813-13E45D5E-5533-4502-93EF-34233C94271C Q48248768-A5487B6A-1B44-46CE-ACAC-650D58876D03 Q48330903-CF6A451D-1E14-4A3A-84D7-E671B1445F76 Q49257885-AD06124C-3355-47D6-82B9-954A0602A42B

P2860

Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.

http://www.wikidata.org/entity/Q36306315

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Impact of breast cancer subtyp ...... analysis spanning two decades.

@ast

Impact of breast cancer subtyp ...... analysis spanning two decades.

@en

type

label

Impact of breast cancer subtyp ...... analysis spanning two decades.

@ast

Impact of breast cancer subtyp ...... analysis spanning two decades.

@en

prefLabel

Impact of breast cancer subtyp ...... analysis spanning two decades.

@ast

Impact of breast cancer subtyp ...... analysis spanning two decades.

@en

P1433

Q36306315-1D3111EE-763F-4B91-8CD4-FC9D529BB2BD

P1476

Q36306315-946E2FEB-26F9-4B0F-A442-643DFACFB39A

P2093

Q36306315-40459B8E-4B50-47DB-A361-3CCE8543E5E7

Q36306315-41DEDA60-5832-48C7-A00C-6336FDDEA6F4

Q36306315-66D120B3-190C-4FCD-A862-8A8BDB443A39

Q36306315-6ACC5411-2644-44A9-9F72-0B3014004C4C

Q36306315-7EFE6E2B-2828-4AD7-B5D1-CC5B531ADFDA

Q36306315-B8E0ED51-B5A8-40BB-A621-5011E4954D45

Q36306315-B901859C-964A-4869-96AA-9723EC9BC761

Q36306315-C10B63ED-BFA2-4EDE-9875-066F0E4F6087

P2860

Q36306315-0F3CAEFD-3336-48C7-AF68-5D85B64213FB

Q36306315-1047551A-E2C4-491C-AB8E-2063F1C0177D

Q36306315-18A670B0-074D-4516-A45B-814F90787E6A

Q36306315-1FBC71D5-156B-407B-A5CA-89813D2CE18E

Q36306315-2A745ADE-3DA2-4977-A86A-E4AD0C95DA8A

Q36306315-35FD9585-F28A-4855-B4A7-CB368C396396

Q36306315-53178F23-A277-45A8-8CDB-1B119E072672

Q36306315-53930B6A-DBC8-4FC2-A2ED-E1FAF5D969AD

Q36306315-63F93DEF-B3A3-4AA0-9ADC-2329B7024F31

Q36306315-6CCE9383-48D0-49C8-B9BE-9875C884C8C1

P304

Q36306315-E485EC7B-A2F4-4A9D-86CB-066A34E14BDA

P31

Q36306315-18FABA23-1284-4004-AD0D-2B450BBBA940

P356

Q36306315-C0F2C9A1-C0A2-4126-9448-B4FEC8D592BC

P433

Q36306315-A7AD53CE-13C6-435E-9D77-E19A497D9EC3

P478

Q36306315-97E3602D-C3BE-43C6-83B5-2F01F4D68253

P50

Q36306315-EB1A008B-B1BB-4A26-993E-3D545EFBF187

P577

Q36306315-B238B248-22B5-4061-AF4A-DD9DA16F5D20

P698

Q36306315-49301709-3C30-4EB7-868B-1FCEEFE52D77

P932

Q36306315-B4D42917-494C-4136-8D66-6D44B07517B9

P356

1055-9965.EPI-12-0474

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Impact of breast cancer subtyp ...... analysis spanning two decades.

@en

P2093

Chantal Avila

http://www.w3.org/2001/XMLSchema#string

Galina Inzhakova

http://www.w3.org/2001/XMLSchema#string

Jiaxiao Shi

http://www.w3.org/2001/XMLSchema#string

Jonathan Polikoff

http://www.w3.org/2001/XMLSchema#string

Michael F Press

http://www.w3.org/2001/XMLSchema#string

Reina Haque

http://www.w3.org/2001/XMLSchema#string

Shelley M Enger

http://www.w3.org/2001/XMLSchema#string

Syed A Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Treatment options for patients with triple-negative breast cancer

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.

Racial and ethnic disparities in the receipt of cancer treatment.

Systems biology and genomics of breast cancer.

Epidemiology of basal-like breast cancer.

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial

P304

1848-1855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-12-0474

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Leslie Bernstein

P577

2012-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22989461

http://www.w3.org/2001/XMLSchema#string

P932

3467337

http://www.w3.org/2001/XMLSchema#string